[Federal Register Volume 86, Number 118 (Wednesday, June 23, 2021)]
[Notices]
[Pages 32976-32977]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13096]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-856]


Bulk Manufacturer of Controlled Substances Application: Purisys, 
LLC.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Purisys, LLC. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before August 23, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before August 23, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on March, 12, 2021, Purisys, LLC., 1550 Olympic Drive, 
Athens, Georgia 30601-1602, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
3,4-Methylenedioxyamphetamine...........    7400  I
3,4-Methylenedioxymethamphetamine.......    7404  I
3,4-Methylenedioxy-N-ethylamphetamine...    7405  I
Psilocybin..............................    7437  I
Psilocyn................................    7438  I
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for the internal use intermediates or for sale to its 
customers. The company plans to manufacture the above-listed controlled 
substances as clinical trial and starting materials to make compounds 
for distribution to its customers. No other

[[Page 32977]]

activity for these drug codes is authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-13096 Filed 6-22-21; 8:45 am]
BILLING CODE P